A Phase 4 interventional study of Diclofenac 75mg and Diclofenac 50mg in Cesarean Section Pain, Diclofenac and Suppository, sponsored by CMH Multan Institute of Medical Sciences. Completed at 1 site in Pakistan. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-01-30.
Sponsored by CMH Multan Institute of Medical Sciences · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies testing diclofenac in Pain, Postoperative — 1 open to participants now, 1 under way, none of them phase 3. Diclofenac · Pain, Postoperative.
Among the 17 studies testing diclofenac in Pain, Postoperative, this one is the 12th largest by enrollment, is one of 2 that started in 2025, is one of 3 in phase 4, and was the 16th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →1 of the 17 studies testing diclofenac in Pain, Postoperative is open now, in 1 country. Recruiting first, the newest first:
Ataturk University · Sites in Turkey
Ages 18–65 · Healthy volunteers
By country, each count listing its studies:
Diclofenac: first FDA approval 1988 (VOLTAREN). What it is approved for, and how studies give it, is on its page →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 20 Years to 45 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 7 · Phase 4 3
First in 2004; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is below the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 98 across the 17 interventional studies. Of the 14 that completed or were terminated, 5 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 17 have an industry lead sponsor. The 10 most frequent:
CMH Multan Institute of Medical Sciences is the lead sponsor of 8 studies on the registry; 2 are open to participants now.
CMH Multan Institute of Medical Sciences has 1 study filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 17 studies testing diclofenac in Pain, Postoperative, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this clinical study is to find out which way of giving diclofenac sodium provides better pain relief after a planned cesarean section: an injection into the muscle or a suppository given through the rectum. Diclofenac is a commonly used pain-relieving medicine after surgery.
Women often experience moderate pain after a cesarean section, and effective pain control helps with early movement, breastfeeding, and overall recovery. Different methods of giving the same medicine may work differently and may affect how comfortable patients feel after surgery. This study compares these two methods to see which one reduces pain more effectively.
Researchers will compare post-operative pain levels in women who receive intramuscular diclofenac with those who receive rectal diclofenac after elective cesarean section.
The main questions this study aims to answer are:
Participants will be women aged 20 to 45 years who are undergoing a planned cesarean section at term. A total of 60 women will take part in the study. They will be randomly assigned to one of two groups:
All participants will receive standard spinal anesthesia for surgery. Pain will be measured using a simple pain scale at 1, 6, 12, and 24 hours after the operation. If a participant reports significant pain, additional pain medicine will be given.
The results of this study will help doctors choose the most effective and comfortable method of pain relief for women after cesarean section.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intramuscular diclofenac will be given for first 24-hours
Drug: Diclofenac 75mg
Diclofenac suppository will be given after caesarean section for first 24-hours
Drug: Diclofenac 50mg
Participants will be given intramuscular diclofenac 75mg 8hourly for first 24-hours after cesarean section
Also known as: Diclofenac sodium, Voltarol
Participants will be given diclofenac suppository every 8 hours for first 24-hours after cesarean section
Postoperative pain
Pain will be assessed on visual analog scale by the blinded assessor
Time frame: Pain will be assessed at 1, 6, 12 and 24-hours after cesarean section
Rescue Analgesia
In cases of VAS \> 4, extra analgesia (rescue analgesia) will be given to control pain
Time frame: From cesarean section to 24-hours postoperatively
Plan to share: No
No publications or documents are linked to this record.
Ran from Feb 2025 to primary completion in Jul 2025, 5 months.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's 5 months is below that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Diclofenac
CMH Multan Institute of Medical Sciences